Fidaxomicin Patent Expiration
Fidaxomicin is Used for treating Clostridioides difficile-associated diarrhea in patients 6 months of age and older. It was first introduced by Cubist Pharmaceuticals Llc
Fidaxomicin Patents
Given below is the list of patents protecting Fidaxomicin, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Dificid |
US9808530 (Pediatric) | Composition of tiacumicin compounds | Nov 28, 2034 | Cubist Pharms Llc |
Dificid | US9808530 | Composition of tiacumicin compounds | May 28, 2034 | Cubist Pharms Llc |
Dificid |
US7378508 (Pediatric) | Polymorphic crystalline forms of tiacumicin B | Jan 31, 2028 | Cubist Pharms Llc |
Dificid |
US7863249 (Pediatric) | Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof | Jan 31, 2028 | Cubist Pharms Llc |
Dificid |
US8859510 (Pediatric) | Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof | Jan 31, 2028 | Cubist Pharms Llc |
Dificid |
US7906489 (Pediatric) | 18-membered macrocycles and analogs thereof | Sep 04, 2027 | Cubist Pharms Llc |
Dificid | US7378508 | Polymorphic crystalline forms of tiacumicin B | Jul 31, 2027 | Cubist Pharms Llc |
Dificid | US7863249 | Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof | Jul 31, 2027 | Cubist Pharms Llc |
Dificid | US7863249 | Macrolide polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof | Jul 31, 2027 | Cubist Pharms Llc |
Dificid | US8859510 | Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof | Jul 31, 2027 | Cubist Pharms Llc |
Dificid | US7906489 | 18-membered macrocycles and analogs thereof | Mar 04, 2027 | Cubist Pharms Llc |
Dificid |
US8586551 (Pediatric) | 18-membered macrocycles and analogs thereof |
Jan 15, 2024
(Expired) | Cubist Pharms Llc |
Dificid | US8586551 | 18-membered macrocycles and analogs thereof |
Jul 23, 2023
(Expired) | Cubist Pharms Llc |
Dificid | US8586551 | 18-membered macrocycles and analogs thereof |
Jul 15, 2023
(Expired) | Cubist Pharms Llc |
Fidaxomicin's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List